Drug recall · May 29, 2019
Amitiza recall
Why: Labeling: Label mix-up. Amitiza 8 mcg capsules are being recalled because 24 mcg capsules were found in a 8 mcg trade 60 ct. bottle. Amitiza 24 mcg capsules are being recalled because a sealed 60 ct. bottle contained only 8 mcg capsules, this incident is being considered as a labeling mix-up issue.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Amitiza (lubiprostone) capsules, 24 mcg, 60-count bottle, Rx only, Manufactured by: Sucampo Pharma Americas, LLC, NDC 64764-240-60
- Lots / codes
Lot #: 3200626-61, Exp 02/2022
- Quantity
- 80,640 bottles
- Company
- Mallinckrodt Pharmaceuticals, Bedminster, NJ
- Distribution
- US Nationwide
- Initiated
- May 13, 2019 · Voluntary: Firm initiated
- Classified
- May 23, 2019
- Reported
- May 29, 2019
- Ended
- July 17, 2023
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Amitiza
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.